The incidence of serious complications after selective laser trabeculoplasty.

IF 2.8 3区 医学 Q1 OPHTHALMOLOGY
Eeva S Ojanen, Joni A Turunen, Mika Harju
{"title":"The incidence of serious complications after selective laser trabeculoplasty.","authors":"Eeva S Ojanen, Joni A Turunen, Mika Harju","doi":"10.1111/aos.17536","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT).</p><p><strong>Methods: </strong>All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018. Data regarding patients' demographics, procedure details, complications, predisposing factors and clinical outcomes were extracted retrospectively from electronic medical records. The primary outcome measures were serious complications, including corneal oedema, corneal scarring, hyperopic shift, synechia, anterior chamber bleeding and hyphema.</p><p><strong>Results: </strong>A total of 6081 SLTs (4601 eyes) of 2812 patients were analysed. Twelve patients had bleeding in the anterior chamber angle (incidence 2/1000 SLT laser treatments), and four of them developed hyphema (incidence 0.7/1000 SLT laser treatments). Corneal oedema or Descemet's membrane folds were reported in six treated eyes, resulting in an incidence of 1/1000. One myopic eye had a permanent corneal scarring, thinning and irregular astigmatism with a hyperopic shift (5.3 D with recovery to 1.25 D in three years), resulting in poor visual acuity (from preoperative 0.9 to 0.4 at the last control). The incidence was less than 0.2/1000 for all SLT treatments (95% CI ≤0.1 to 1.0) and 1/648 for SLT laser treatments in high myopia (spherical equivalent ≤-5.00 D).</p><p><strong>Conclusions: </strong>After SLT, the number of complications was low, with only one permanent vision deterioration after 6081 treatments. These findings may help clinicians reassure patients about SLT safety when offering SLT as a first-line treatment for ocular hypertension or open-angle glaucoma.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/aos.17536","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT).

Methods: All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018. Data regarding patients' demographics, procedure details, complications, predisposing factors and clinical outcomes were extracted retrospectively from electronic medical records. The primary outcome measures were serious complications, including corneal oedema, corneal scarring, hyperopic shift, synechia, anterior chamber bleeding and hyphema.

Results: A total of 6081 SLTs (4601 eyes) of 2812 patients were analysed. Twelve patients had bleeding in the anterior chamber angle (incidence 2/1000 SLT laser treatments), and four of them developed hyphema (incidence 0.7/1000 SLT laser treatments). Corneal oedema or Descemet's membrane folds were reported in six treated eyes, resulting in an incidence of 1/1000. One myopic eye had a permanent corneal scarring, thinning and irregular astigmatism with a hyperopic shift (5.3 D with recovery to 1.25 D in three years), resulting in poor visual acuity (from preoperative 0.9 to 0.4 at the last control). The incidence was less than 0.2/1000 for all SLT treatments (95% CI ≤0.1 to 1.0) and 1/648 for SLT laser treatments in high myopia (spherical equivalent ≤-5.00 D).

Conclusions: After SLT, the number of complications was low, with only one permanent vision deterioration after 6081 treatments. These findings may help clinicians reassure patients about SLT safety when offering SLT as a first-line treatment for ocular hypertension or open-angle glaucoma.

选择性激光小梁成形术后严重并发症的发生率。
目的:评价选择性激光小梁成形术(SLT)术后严重并发症的发生率。方法:2012年1月1日至2018年12月31日在赫尔辛基大学医院眼科接受SLT治疗的所有患者均符合研究条件。从电子病历中回顾性提取有关患者人口统计学、手术细节、并发症、易感因素和临床结果的数据。主要结局指标为严重并发症,包括角膜水肿、角膜瘢痕、远视移位、粘连、前房出血和前房积血。结果:共分析2812例患者6081例slt(4601眼)。12例发生前房角出血(发生率为2/1000),4例发生前房积血(发生率为0.7/1000)。6只治疗眼出现角膜水肿或Descemet膜褶皱,发生率为1/1000。1只近视眼有永久性角膜瘢痕、变薄和不规则散光,并有远视移位(5.3 D, 3年后恢复到1.25 D),导致视力差(从术前的0.9到最后一次对照的0.4)。所有SLT治疗的发生率均小于0.2/1000 (95% CI≤0.1 ~ 1.0),高度近视(球面等效度≤-5.00 D) SLT激光治疗的发生率小于1/648。结论:SLT术后并发症发生率低,6081例术后仅发生1例永久性视力下降。这些发现可能有助于临床医生在将SLT作为高眼压或开角型青光眼的一线治疗时,向患者保证SLT的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Ophthalmologica
Acta Ophthalmologica 医学-眼科学
CiteScore
7.60
自引率
5.90%
发文量
433
审稿时长
6 months
期刊介绍: Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER). Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信